ESPE Abstracts (2019) 92 RFC8.2

ESPE2019 Rapid Free Communications Pituitary, Neuroendocrinology and Puberty Session 1 (6 abstracts)

Investigation of Imprinting Alterations in MKRN3 and DLK1 in a Cohort of Girls with Central Precocious Puberty Through Specific DNA Methylation Analysis

Ana Canton 1 , Virginie Steunou 2,3 , Vinicius Brito 1 , Marie Laure Sobrier 2,3 , Luciana Montenegro 1 , Danielle Bessa 1 , Berenice B Mendonca 1 , Irène Netchine 2,3 & Ana Claudia Latronico 1


1Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. 2Sorbonne Université, INSERM, UMRS 938, Centre de Recherche Saint-Antoine, Paris, France. 3AP-HP, Hôpital Trousseau, Service d'Explorations Fonctionelles Endocriniennes, Paris, France


Background: Loss of imprinting has been implicated in the pathogenesis of several human diseases. Monogenic causes of central precocious puberty (CPP) were identified in families with loss-of-function mutations in two paternally expressed imprinted genes: Makorin zinc finger 3 (MKRN3) and Delta-like 1 homolog (DLK1). The role of imprinting defects in CPP has not been described so far.

Objective: To investigate the methylation status at primary differentially methylated regions (DMR) of MKRN3 and DLK1 in a cohort of CPP patients.

Patients and Methods: Fifty-six CPP girls (48 sporadic, 8 familial) were selected for analysis. They had normal hypothalamic-pituitary region MRI. Leukocyte DNA was obtained from all patients. MKRN3 and DLK1 pathogenic allelic variants were initially excluded by DNA sequencing analysis. Bisulfite treatment followed by Allele-Specific Methylated Multiplex Real-Time Quantitative PCR was performed with leukocyte DNA, analyzing separately the methylation index (MI) of MKRN3:TSS-DMR and DLK1/MEG3:IG-DMR for each patient. Results were compared with MI of 50 adult controls, 15 prepubertal controls girls and 18 pubertal controls girls with normal pubertal development.

Results: Mean age at puberty onset was 6.1±1.9yr for all CPP girls. Hypomethylation at DLK1/MEG3:IG-DMR was identified in two patients with sporadic CPP (patients I and II), confirming a molecular diagnosis of Temple syndrome. Interestingly, both girls had been firstly referred to pediatric endocrinology for presenting precocious menarche. During follow-up, other clinical findings were noticed: being born small for gestational age, prominent forehead, small hands/feet, overweight and hyperinsulinemia or early type 2 diabetes. SNP array was performed in patient I, identifying a partial uniparental disomy at chromosome 14 (upd(14)). On the other hand, patient II had normal CGH array and microsatellites analysis, excluding copy number variations and upd(14), and indicating a mechanism of epimutation. In the remaining patients, mean MI for DLK1/MEG3:IG-DMR was 49±1.5%. In all patients, mean MI for MKRN3:TSS-DMR was 49±5%. Besides that, as a group, there were no significant correlations between age at puberty onset and: 1) MI for MKRN3:TSS-DMR (P=0,69) and 2) MI for DLK1/MEG3:IG-DMR (P=0,45).

Conclusion: There were no leukocyte DNA methylation defects at MKRN3 imprinting control region. DLK1/MEG3:IG-DMR hypomethylation was identified in two patients with CPP. Loss of effective imprinting of DLK1 locus may be a mechanism involved in the etiology of CPP, and should be investigated in patients presenting additional findings of Temple syndrome.

Volume 92

58th Annual ESPE (ESPE 2019)

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.